• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Understanding Glaucoma: Why it Remains a Leading Cause of Blindness Worldwide.了解青光眼:为何它仍是全球失明的主要原因。
Klin Monbl Augenheilkd. 2025 Jul;242(7):712-717. doi: 10.1055/a-2617-1575. Epub 2025 Jul 24.
2
Global causes of blindness and distance vision impairment 1990-2020: a systematic review and meta-analysis.全球失明和远距离视力损伤原因 1990-2020:系统回顾和荟萃分析。
Lancet Glob Health. 2017 Dec;5(12):e1221-e1234. doi: 10.1016/S2214-109X(17)30393-5. Epub 2017 Oct 11.
3
Spinal Muscular Atrophy脊髓性肌萎缩症
4
Global burden of vision impairment due to age-related macular degeneration, 1990-2021, with forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2021.1990年至2021年因年龄相关性黄斑变性导致的视力损害全球负担,以及到2050年的预测:全球疾病负担研究2021的系统分析
Lancet Glob Health. 2025 Jul;13(7):e1175-e1190. doi: 10.1016/S2214-109X(25)00143-3.
5
Management of urinary stones by experts in stone disease (ESD 2025).结石病专家对尿路结石的管理(2025年结石病专家共识)
Arch Ital Urol Androl. 2025 Jun 30;97(2):14085. doi: 10.4081/aiua.2025.14085.
6
The clinical effectiveness and cost-effectiveness of screening for open angle glaucoma: a systematic review and economic evaluation.开角型青光眼筛查的临床有效性和成本效益:系统评价与经济学评估
Health Technol Assess. 2007 Oct;11(41):iii-iv, ix-x, 1-190. doi: 10.3310/hta11410.
7
Fornix-based versus limbal-based conjunctival trabeculectomy flaps for glaucoma.用于青光眼的穹窿部结膜小梁切除术瓣与角膜缘部结膜小梁切除术瓣对比
Cochrane Database Syst Rev. 2015 Nov 25;11(11):CD009380. doi: 10.1002/14651858.CD009380.pub2.
8
Sexual Harassment and Prevention Training性骚扰与预防培训
9
Device-modified trabeculectomy for glaucoma.用于青光眼的设备改良小梁切除术
Cochrane Database Syst Rev. 2015 Dec 1;2015(12):CD010472. doi: 10.1002/14651858.CD010472.pub2.
10
-Related Marfan Syndrome-相关马凡综合征

本文引用的文献

1
Barriers to the uptake of eye care services: A cross-sectional survey from rural and urban communities.眼科保健服务利用的障碍:来自农村和城市社区的横断面调查。
PLoS One. 2024 Aug 15;19(8):e0308294. doi: 10.1371/journal.pone.0308294. eCollection 2024.
2
Patient Experience and Barriers to the Visual Field Test for Glaucoma.患者的视野检查体验及障碍因素对青光眼的影响。
J Glaucoma. 2024 Nov 1;33(11):835-840. doi: 10.1097/IJG.0000000000002477. Epub 2024 Aug 1.
3
Epidemiology and Treatment of Patients With Primary Open Angle Glaucoma in Germany: A Health Claims Data Analysis.德国原发性开角型青光眼患者的流行病学和治疗:一项健康索赔数据分析。
J Glaucoma. 2024 Aug 1;33(8):549-558. doi: 10.1097/IJG.0000000000002420. Epub 2024 May 17.
4
The Epidemiology of Glaucoma - an Age-Related Disease.青光眼的流行病学——一种与年龄相关的疾病。
Klin Monbl Augenheilkd. 2024 Feb;241(2):154-161. doi: 10.1055/a-2257-6940. Epub 2024 Feb 27.
5
Machine Learning-Derived Baseline Visual Field Patterns Predict Future Glaucoma Onset in the Ocular Hypertension Treatment Study.机器学习衍生的基线视野模式可预测青光眼在高眼压治疗研究中的发病。
Invest Ophthalmol Vis Sci. 2024 Feb 1;65(2):35. doi: 10.1167/iovs.65.2.35.
6
Genomics enabling personalised glaucoma care.基因组学助力青光眼个体化诊疗。
Br J Ophthalmol. 2023 Dec 18;108(1):5-9. doi: 10.1136/bjo-2023-324618.
7
Identifying, Understanding, and Addressing Disparities in Glaucoma Care in the United States.美国青光眼护理中的差异识别、理解和处理。
Transl Vis Sci Technol. 2023 Oct 3;12(10):18. doi: 10.1167/tvst.12.10.18.
8
10 Years of GWAS in intraocular pressure.眼压全基因组关联研究的十年
Front Genet. 2023 Apr 12;14:1130106. doi: 10.3389/fgene.2023.1130106. eCollection 2023.
9
Cohort Study of Race/Ethnicity and Incident Primary Open-Angle Glaucoma Characterized by Autonomously Determined Visual Field Loss Patterns.种族/民族与自主确定的视野丧失模式特征的原发性开角型青光眼发病的队列研究。
Transl Vis Sci Technol. 2022 Jul 8;11(7):21. doi: 10.1167/tvst.11.7.21.
10
Social differences in mortality and life expectancy in Germany. Current situation and trends.德国死亡率和预期寿命的社会差异。现状与趋势。
J Health Monit. 2019 Mar 14;4(1):3-14. doi: 10.25646/5872. eCollection 2019 Mar.

了解青光眼:为何它仍是全球失明的主要原因。

Understanding Glaucoma: Why it Remains a Leading Cause of Blindness Worldwide.

作者信息

Qi Tienan, Liu Hanhan, Frühn Layla, Löw Katrin, Cursiefen Claus, Prokosch Verena

机构信息

Zentrum für Augenheilkunde, Medizinische Fakultät, Universität Köln, Deutschland.

出版信息

Klin Monbl Augenheilkd. 2025 Jul;242(7):712-717. doi: 10.1055/a-2617-1575. Epub 2025 Jul 24.

DOI:10.1055/a-2617-1575
PMID:40719087
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12302165/
Abstract

Glaucoma is one of the leading causes of irreversible blindness worldwide and is often referred to as the "silent thief of sight", because it often progresses without noticeable symptoms until significant vision loss occurs. With an estimated 76 million patients affected in 2020 and a forecast of over 111 million by 2040, the global situation requires urgent attention. Vision loss caused by glaucoma is irreversible but largely preventable, highlighting the importance of early detection and treatment. Diagnosis presents significant challenges, particularly due to the asymptomatic nature of the disease and age-related risk factors. Inequalities in care and access to appropriate treatments are other barriers leading to delayed diagnoses. Early diagnosis and interventions are critical to slow disease progression, protect remaining vision and improve the quality of life of those affected. These measures are particularly important to minimise the psychological impact and impairment in daily activities. The use of innovative technologies and targeted interventions could help improve the early detection and treatment of glaucoma and thus reduce the risk of irreversible vision loss.

摘要

青光眼是全球不可逆性失明的主要原因之一,常被称为“视力的无声窃贼”,因为它通常在没有明显症状的情况下进展,直到出现严重视力丧失才被发现。2020年估计有7600万患者受影响,预计到2040年将超过1.11亿,全球形势亟需关注。青光眼导致的视力丧失是不可逆的,但在很大程度上是可预防的,这凸显了早期发现和治疗的重要性。诊断面临重大挑战,特别是由于该疾病无症状的性质以及与年龄相关的风险因素。医疗保健方面的不平等以及获得适当治疗的机会是导致诊断延迟的其他障碍。早期诊断和干预对于减缓疾病进展、保护剩余视力以及改善患者生活质量至关重要。这些措施对于将心理影响和日常活动中的损伤降至最低尤为重要。使用创新技术和有针对性的干预措施有助于改善青光眼的早期发现和治疗,从而降低不可逆视力丧失的风险。